A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.
Clinical trial NCT06206837 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06206837
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-02-19
- Primary completion
- 2025-09-05
- Enrollment
- 71
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.